Financing Drug Discovery for Orphan Diseases

While pharmaceutical R&D budgets grow larger, getting drug approval only gets harder—which may ultimately jeopardize financing for drug development. A proposed "megafund" financing method could be the answer, and its chances of success are likely to be even greater for orphan drug development.

Learn more about the 'megafund' (PDF, 173kb)